Hutch News

Hutch News

Stories tagged 'Diseases'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 21, 2017

Dr. Mohamed Sorror and colleagues have developed a novel, online risk-assessment tool for patients with acute myeloid leukemia.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 14, 2017

An immunotherapy technology developed by Dr. Brian Till with Dr. Oliver Press at Fred Hutchinson Cancer Research Center has been licensed by Mustang Bio Inc., a subsidiary of the biopharmaceutical company Fortress Biotech Inc. The exclusive, worldwide license, announced Sept. 14 by Mustang Bio, will allow a new type of CAR (chimeric antigen receptor) T-cell therapy to be tested in a clinical trial as a treatment for B-cell non-Hodgkin lymphomas. The novel immunotherapy targets CD20, a protein marker on cancer cells in lymphoma.

View story >


Big study finds no rise in death risk among women who took hormone therapy

A new twist to menopausal hormone replacement dilemma

Sept. 12, 2017 | Sabin Russell / Fred Hutch News Service

New follow-up research to a landmark study on menopausal hormone replacement therapy has found that women assigned to those drugs on the study had no higher risk of death than women who took a placebo.

View story >


5 things you can do to reduce your risk of colorectal cancer

Healthy prevention tips from a new data analysis of studies on 29 million adults: move your body, cancer-proof your plate

Sept. 6, 2017 | By Diane Mapes / Fred Hutch News Service

A new report by an international panel of scientists, including Fred Hutch cancer prevention researcher Dr. Anne McTiernan, breaks down the impact diet and physical activity can have on colorectal cancer.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Aug. 31, 2017

Fred Hutchinson Cancer Research Center has become the first U.S. cancer center to join a growing coalition pledging to advance diversity and inclusion in the workplace. On Aug. 25, Fred Hutch President and Director Dr. Gary Gilliland joined more than 270 CEOs nationwide who have taken the pledge as part of the CEO Action for Diversity & Inclusion.™

View story >


New guidelines take aim at chemo-related nausea

Cancer patients ‘should not be vomiting with chemo anymore.’ Can someone please tell Hollywood?

Aug. 24, 2017 | By Diane Mapes / Fred Hutch News Service

Nausea and vomiting is a weird thing to … uh … bring up, writes cancer survivor Diane Mapes. But a lot of people don't seem to realize these common chemo side effects are now well controlled with anti-nausea drugs. New guidelines, co-written by Fred Hutch's Dr. Gary Lyman, break it all down.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.